NASDAQ:ABMDABIOMED Stock Price, Forecast & News

ABIOMED's stock was trading at $151.13 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ABMD stock has increased by 74.6% and is now trading at $263.84. View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ABIOMED in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for ABIOMED.

ABIOMED is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for ABIOMED.

ABIOMED, Inc. (NASDAQ:ABMD) issued its quarterly earnings results on Thursday, April, 30th. The medical equipment provider reported $0.70 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.96 by $0.26. The medical equipment provider earned $206.66 million during the quarter, compared to the consensus estimate of $209.58 million. ABIOMED had a return on equity of 18.51% and a net margin of 24.14%. ABIOMED's revenue for the quarter was down .2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.60 earnings per share. View ABIOMED's earnings history.

8 brokerages have issued 12 month target prices for ABIOMED's shares. Their forecasts range from $152.00 to $240.00. On average, they expect ABIOMED's share price to reach $193.00 in the next twelve months. This suggests that the stock has a possible downside of 26.8%. View analysts' price targets for ABIOMED.

Press coverage about ABMD stock has trended somewhat positive on Saturday, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ABIOMED earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View the latest news about ABIOMED.

ABIOMED saw a decrease in short interest in June. As of June 15th, there was short interest totaling 2,730,000 shares, a decrease of 5.2% from the May 31st total of 2,880,000 shares. Based on an average daily trading volume, of 660,500 shares, the short-interest ratio is currently 4.1 days. Currently, 6.2% of the shares of the company are sold short. View ABIOMED's Current Options Chain.

Some companies that are related to ABIOMED include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Steris (STE) and Insulet (PODD). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other ABIOMED investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Align Technology (ALGN), Netflix (NFLX), Arista Networks (ANET), Square (SQ), Paypal (PYPL), salesforce.com (CRM) and Adobe (ADBE).

ABIOMED trades on the NASDAQ under the ticker symbol "ABMD."

Shares of ABMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ABMD stock can currently be purchased for approximately $263.84.

ABIOMED has a market capitalization of $11.88 billion and generates $840.88 million in revenue each year. The medical equipment provider earns $203.01 million in net income (profit) each year or $4.74 on an earnings per share basis. ABIOMED employs 1,536 workers across the globe.

The official website for ABIOMED is www.abiomed.com.

ABIOMED's mailing address is 22 CHERRY HILL DR, DANVERS MA, 01923. The medical equipment provider can be reached via phone at 978-646-1400 or via email at [email protected]